Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
15
pubmed:dateCreated
2007-8-2
pubmed:abstractText
Tumor necrosis factor (TNF)-induced inflammation prevents its broad application as an antitumor agent. We here report that addition of ZnSO(4) to the drinking water of mice induces expression of heat shock protein 70 (HSP70) in several organs, notably the gastrointestinal track. Zinc conferred dose-responsive protection against TNF-induced hypothermia, systemic induction of interleukin-6 and NO(x), as well as against TNF-induced bowel cell death and death of the organism. The protective effect of zinc was completely absent in mice deficient in the major HSP70-inducible gene, hsp70.1, whereas transgenic mice constitutively expressing the human HSP70.A gene, under control of a beta-actin promoter, was also protected against TNF, indicating that an increase in HSP70 is necessary and sufficient to confer protection. The therapeutic potential of the protection induced by ZnSO(4) was clearly shown in a TNF/IFNgamma-based antitumor therapy using three different tumor models. In hsp70.1 wild-type mice, but not in hsp70.1-deficient mice, zinc very significantly protected against lethality but left the antitumor effect intact. We conclude that zinc protects against TNF in a HSP70-dependent way and that protection by zinc could be helpful in developing a safer anticancer therapy with TNF/IFNgamma.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0008-5472
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
67
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7301-7
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:17671199-Animals, pubmed-meshheading:17671199-Antineoplastic Agents, pubmed-meshheading:17671199-Antiviral Agents, pubmed-meshheading:17671199-Dose-Response Relationship, Drug, pubmed-meshheading:17671199-Female, pubmed-meshheading:17671199-HSP70 Heat-Shock Proteins, pubmed-meshheading:17671199-Humans, pubmed-meshheading:17671199-Hypothermia, pubmed-meshheading:17671199-Inflammation, pubmed-meshheading:17671199-Interferon-gamma, pubmed-meshheading:17671199-Interleukin-6, pubmed-meshheading:17671199-Intestine, Small, pubmed-meshheading:17671199-Mice, pubmed-meshheading:17671199-Mice, Inbred C57BL, pubmed-meshheading:17671199-Mice, Knockout, pubmed-meshheading:17671199-Mice, Transgenic, pubmed-meshheading:17671199-Necrosis, pubmed-meshheading:17671199-Neoplasms, Experimental, pubmed-meshheading:17671199-Survival Rate, pubmed-meshheading:17671199-Tumor Cells, Cultured, pubmed-meshheading:17671199-Tumor Necrosis Factor-alpha, pubmed-meshheading:17671199-Zinc Sulfate
pubmed:year
2007
pubmed:articleTitle
Protection of zinc against tumor necrosis factor induced lethal inflammation depends on heat shock protein 70 and allows safe antitumor therapy.
pubmed:affiliation
Department for Molecular Biomedical Research, VIB, Ghent, Belgium.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't